Clinical Trials in California

Showing 9121-9140 of 11,359 trials

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

NCT00284804

This study is designed to determine the objective response rate in patients with relapsed or refractory Hodgkin's disease treated with MDX-060 in combination with gemcitabine or gemcitabine alone.

Hodgkin's Disease

Bristol-Myers Squibb74 participantsStarted Nov 2005

Duarte, California, United States • Fresno, California, United States • La Jolla, California, United States +14 more locations

COMPLETEDPhase 344 miles

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

NCT01912391

Selegiline is superior to placebo in improving psychological and physical functioning in patients with Borderline Personality Disorder.

Borderline Personality Disorder

Mood and Anxiety Research, Inc30 participantsStarted Oct 2012

Fresno, California, United States

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

Find Trials by Condition in California

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

PoC in Rheumatoid Arthritis With Methotrexate

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Pioglitazone in Early Parkinson's Disease

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Phase II, 2nd Line Melanoma - RAND Monotherapy

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

Self Selection Trial of Naproxen Sodium

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Brain Metastases In ErbB2-Positive Breast Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment